Address
Email address
Phone number
https://tbdpharmatech.comTBD Pharmatech – Contract Development and ManufacturingTBD Pharmatech specialises in Active Pharmaceutical Ingredients, advanced intermediates, and the development and production of fine chemicals
Name
OÜ KALTEC
Registry code
10804159
VAT number
EE101176082
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
27.11.2001 (22)
Financial year
01.01-31.12
Capital
2 566.00 €
Activity
70221 - Business and other management consultancy activities
170 750 €
34 728 €
20%
-
2 390 404 €
0
Submitted
No tax arrears
1%
1%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Andrus Tasa 10.01.1966 (58) | 100% - 2 566.00 EUR | Board member | Direct ownership | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| aktsiaselts Biotehnoloogia Park Kinnisvara 10834232 | 50% - 74 124.00 EUR | - | - | FounderShareholder |
| ToxInvent OÜ 12805625 | 100% - 4 223.00 EUR | - | - | Founder |
| KemInvent OÜ 12771636 | 59% - 3 496.00 EUR | - | - | FounderFounder |
| osaühing Technologicum 11318780 | 100% - 2 556.00 EUR | - | - | |
| DosCero OÜ 16694813 | - | - | - | Founder |
| Marecrona OÜ 16694826 | - | - | - | Founder |
| Tartu BT Park OÜ 14217720 | - | - | - | Founder |
| Baltic Innovation Agency OÜ 10943240 | - | - | - | Founder |
| 2019 31.07.2020 | 2020 01.07.2021 | 2021 29.05.2022 | 2022 03.07.2023 | 2023 18.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 314 350 € | 521 395 € | 582 229 € | 664 242 € | 170 750 € |
| Net profit (loss) for the period | 344 290 € | 508 419 € | 663 833 € | 143 862 € | 34 728 € |
| Profit Margin | 110% | 98% | 114% | 22% | 20% |
| Current Assets | 739 494 € | 1 188 731 € | 1 805 074 € | 1 963 135 € | 1 815 675 € |
| Fixed Assets | 440 778 € | 414 689 € | 463 498 € | 435 239 € | 575 875 € |
| Total Assets | 1 180 272 € | 1 603 420 € | 2 268 572 € | 2 398 374 € | 2 391 550 € |
| Current Liabilities | 87 601 € | 2 330 € | 1 758 € | 22 698 € | 1 146 € |
| Non Current Liabilities | 0 € | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 1 092 671 € | 1 601 090 € | 2 266 814 € | 2 375 676 € | 2 390 404 € |
| Employees | 1 | 1 | 1 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 16 900 € | 2 705.56 € | 357.39 € | - |
| 2023 Q4 | 4 300 € | 483.09 € | 357.39 € | - |
| 2023 Q3 | 18 100 € | 514.68 € | 357.39 € | - |
| 2023 Q2 | 144 050 € | 25 232.25 € | 357.39 € | - |
| 2023 Q1 | 88 240 € | 21 079.13 € | 357.39 € | - |
| 2022 Q4 | 14 400 € | 2 346.54 € | 357.39 € | - |
| 2022 Q3 | 304 822 € | 58 925.38 € | 357.39 € | - |
| 2022 Q2 | 140 000 € | 20 579.32 € | 257.39 € | - |
| 2022 Q1 | 120 195 € | 23 766.3 € | 331.12 € | - |
| 2021 Q4 | 177 150 € | 36 032.69 € | 1 529.31 € | - |
| 2021 Q3 | 314 414 € | 43 009.4 € | 377.17 € | 1 |
| 2021 Q2 | 92 600 € | 18 557.03 € | 462.06 € | 1 |
| 2021 Q1 | 17 600 € | 3 538.56 € | 462.06 € | 1 |
| 2020 Q4 | 115 600 € | 22 457.36 € | 462.06 € | 1 |
| 2020 Q3 | 136 550 € | 26 887.44 € | 513.4 € | 1 |
| 2020 Q2 | 123 922.38 € | 25 133.52 € | 616.08 € | 1 |
| 2020 Q1 | 143 800 € | 29 058.27 € | 616.08 € | - |
